2023³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦ 35Â÷ °¡À» Çмú´ëȸ(1ÀÏÂ÷) : 2023-09-01
±³À°ÀÏÀÚ : 2023-09-01
±³À°Àå¼Ò : ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ : 2023³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦ 35Â÷ °¡À» Çмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѼ¼Æ÷º´¸®ÇÐȸ
´ã´çÀÚ : ±èÀºÁ¤
¿¬¶ôó : 02-593-6943
À̸ÞÀÏ : cytopathology@hanmail.net
±³À°Á¾·ù : º´¸®°ú
Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : Àü¶óºÏµµ
±³À°½Ã°£ : 4 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Àü¹®ÀÇȸ¿ø 7¸¸¿ø / Àü°øÀÇ,Á¶±³,±ºÀÇ°üȸ¿ø 4¸¸¿ø / ¼¼Æ÷º´¸®»çȸ¿ø 4¸¸¿ø / ºñȸ¿ø 10¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 11:10~12:00 Ư°: 2023 ´ëÇÑ°©»ó¼±ÇÐȸ °©»ó¼±°áÀý Áø·á ±Ç°í¾È(2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules) ¹Ú¿µÁÖ(¼¿ïÀÇ´ë)
ÈÞ½Ä 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 12:00~13:10 Á¡½É ( )
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 13:10~13:50 ½ÉÆ÷Áö¾ö ¥°: The Bethesda system for reporting thyroid cytopathology 3rd edition ¼Ûµ¿Àº(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 13:50~14:30 ½ÉÆ÷Áö¾ö ¥°: The WHO System for reporting lung cytopathology Â÷ÈñÁ¤(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 14:30~15:10 ½ÉÆ÷Áö¾ö ¥°: The WHO System for reporting lymph node cytopathology Á¤Çý¶ó(°è¸íÀÇ´ë)
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 15:10~15:50 ½ÉÆ÷Áö¾ö ¥°: Updates to the Milan System ½Å¼öÁø(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 15:50~16:10 Coffee break ( )
±âŸ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 16:10~16:40 ÃÑȸ ( )
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 16:40~16:56 ½½¶óÀ̵弼¹Ì³ª: °©»ó¼± (Anaplastic thyroid carcinoma with osteoclast-like giant cells) ÀÌÁö¿µ(ȼøÀü³²´ëº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 16:56~17:12 ½½¶óÀ̵弼¹Ì³ª: Salivary gland (Amylase crystalloids in Warthin tumor) È«¶õ(Á¶¼±´ëº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 17:12~17:28 ½½¶óÀ̵弼¹Ì³ª: º¹¼ö (Sertoli-Leydig cell tumor) ÃÖ¼ÛÀÌ(Ãæ³²´ëº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 17:28~17:44 ½½¶óÀ̵弼¹Ì³ª: °©»ó¼± (Primary thyroid diffuse large B-cell lymphoma) ¾È¾Ö¸®(ÀüºÏ´ëº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 17:44~18:00 ½½¶óÀ̵弼¹Ì³ª: ºÎ°©»ó¼± (ATYPICAL CELLS, FAVOR RECURRENT PARATHYROID NEOPLASM) È«¿ø±â(¼¿ï¾Æ»êº´¿ø)
±âŸ 09¿ù 01ÀÏ ±º»ê»õ¸¸±ÝÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 18:10~20:30 Á¦ 20Â÷ ÇÑÀÏÇÐȸ ±â³ä½Ä ¹× ¸¸Âù ( )